This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Science and Research
Leber hereditary optic neuropathy (LHON) research
From mitochondrial research to gene editing, our scientists take a number of approaches to investigate this rare inherited condition and strive to develop future treatments.
Overview
Why this research is important
LHON causes profound loss of central vision (sharpness and colour). It makes reading, driving and recognising faces difficult. We know that central vision is lost because of damage to the optic nerve cells at the back of the eye.
LHON vision loss is most common between the ages of 18-32 years. Our research aims to make discoveries that will lead to treatments to prevent or reverse this devastating condition.
Key research questions
- What are the cellular and molecular changes that occur in LHON?
- What genetic and environment factors protect or trigger vision loss in people with LHON?
- Can genetic editing technology provide treatment options?
- Can understanding the lived experience of people directly or indirectly affected by LHON guide the development of resources or inform research priorities?
-
Do large red blood cells increase the risk of vision loss from LHON?